By the time a patient sits down in my office and tells me they’ve already tried “three preventives and nothing worked,” my first question usually isn’t about a new drug — it’s about which three, at what dose, and for how long. But when the list really is complete — topiramate stopped for brain fog, propranolol stopped for fatigue, amitriptyline stopped for ten pounds of weight gain — I often bring up a medication that surprises people every time: candesartan, a blood pressure pill that happens to be one of the better-studied migraine preventives nobody ever mentions to them.
How a Blood Pressure Pill Ended Up on a Migraine Prescription Pad
This isn’t as strange as it sounds. Two of the oldest and most widely used migraine preventives, propranolol and verapamil, are also blood pressure medications. Nobody fully understands why drugs built to relax blood vessels or slow the heart also quiet the trigeminovascular system that drives migraine, but the clinical effect has been observed and re-tested for decades. Candesartan belongs to a class called angiotensin II receptor blockers, or ARBs — the same family as losartan and valsartan — and it turned up as a migraine preventive somewhat by accident, when researchers in Norway noticed that migraine patients being treated for hypertension were also reporting fewer headache days.
What the Evidence Actually Shows
The trial that put candesartan on the map was a randomized, placebo-controlled crossover study published in JAMA in 2003, which found that 16 mg daily cut migraine days by roughly a third compared to placebo — a magnitude similar to what we see with standard preventives. A follow-up head-to-head trial in 2014 compared candesartan directly against propranolol and found them roughly equivalent in effectiveness, with a slightly gentler side-effect profile for candesartan. European headache societies list ARBs as a reasonable preventive option on the strength of this data. I want to be transparent about one thing, though: candesartan is not FDA-approved for migraine in the United States, unlike propranolol and topiramate. When I prescribe it, it’s off-label, which is common practice in headache medicine but worth naming plainly rather than glossing over.
Who I Actually Consider It For
Candesartan isn’t my default first choice — I still start most patients on a beta-blocker or topiramate, largely because they have more trial data behind them and I know their side-effect patterns cold. But candesartan moves up my list quickly in a few situations. If a patient’s blood pressure is already running high-normal, treating two problems with one prescription is appealing and avoids adding a fourth pill bottle to the counter. If someone couldn’t tolerate the cognitive slowing of topiramate, the fatigue or mood flattening of propranolol, or the weight gain and dry mouth of amitriptyline, candesartan is usually the best-tolerated option I have left in a similar efficacy range. It’s also useful for patients who are understandably wary of weight change, since it tends to be weight-neutral.
It is not an option during pregnancy — ARBs are contraindicated because of documented fetal kidney injury, and this is a firm line, not a relative caution. I also avoid it, or use it carefully with lab monitoring, in patients with significant kidney disease, in anyone already prone to low blood pressure, and in patients taking potassium-sparing diuretics or potassium supplements, since ARBs can raise potassium levels.
What Starting It Actually Looks Like
I usually start at 8 mg once daily and increase to 16 mg after a week or two if it’s well tolerated, which matches the dose used in the trials that showed benefit. Some patients do better pushed a bit higher, up to 32 mg, though that’s a smaller and less-studied step. Before starting, I check a baseline blood pressure and a basic metabolic panel — mainly potassium and kidney function — and I repeat that panel after any dose increase in patients with other risk factors. The most common early side effect is mild lightheadedness in the first several days, which usually settles as the body adjusts; a true drop in blood pressure severe enough to cause fainting is uncommon at these doses.
The part patients underestimate with every migraine preventive, candesartan included, is the timeline. This is not a rescue medication, and it will not do anything for the migraine you have today. Like topiramate or propranolol, it typically needs eight to twelve weeks at an effective dose before you can fairly judge whether it’s working. I ask patients to keep a simple headache diary through that window — days with headache, rough severity, medication used — because memory alone tends to either overstate or understate a 30–40% reduction in headache days, and that’s exactly the range where these medications tend to land.
If Candesartan Doesn’t Work Either
Sometimes it doesn’t, and that’s useful information, not a dead end. Failing a fourth preventive class is one of the clearer signals that it’s time to talk about CGRP-targeted therapies — the monoclonal antibody injections or the newer oral gepants — which work through a different pathway entirely and don’t require this same trial-and-error with side effects. I’ve written in more detail about when and how to switch migraine preventives, and about the specific trade-offs of topiramate and propranolol, if you’re trying to figure out where you are in that sequence. And if you’ve been told your headaches are “just migraine” but nothing you try actually moves the needle, it’s worth reading why some headaches don’t get better — because occasionally the preventive isn’t the problem; the diagnosis is.
What I want you to take from this isn’t that candesartan is a miracle drug — it isn’t, and it fails plenty of patients too. It’s that the standard three preventives are not the whole list, and if you’ve stopped all of them for side effects rather than lack of benefit, there are still reasonable, evidence-based options your doctor may not have raised yet. It’s worth asking about by name.
Next Steps
If you’re unsure whether your headaches need more urgent evaluation, start with our free headache red flags checklist. If you’d like to talk through your specific history and preventive options, you can schedule a consultation with a specialist.
This article is for educational purposes only and is not a substitute for individualized medical care. If you’re experiencing a sudden, severe, or unusual headache — especially the worst headache of your life, a headache with fever and neck stiffness, or a headache with weakness, confusion, or vision loss — seek emergency care immediately.
From the textbook. Chapter 15, “Preventive Treatment I: The Oral Preventives,” of my clinical textbook Headache Medicine covers this topic in full for doctors, with the evidence and decision pathways behind it. About the book →